Related Experiment Video
Updated: Jul 3, 2025

Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Published on: August 27, 2021
Vitiligo non-responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may
Nathaniel B Goldstein1, Andrea Steel1, Landon Tomb1
1Department of Dermatology, University of Colorado, Aurora, Colorado, USA.
Abstract:
We have discovered that human vitiligo patients treated with narrow-band UVB (NBUVB) demonstrated localized resistance to repigmentation in skin sites characterized by distinct cellular and molecular pathways. Using immunostaining studies, discovery-stage RNA-Seq analysis, and confirmatory in situ hybridization, we analyzed paired biopsies collected from vitiligo lesions that did not repigment after 6 months of NBUVB treatment (non-responding) and compared them with repigmented (responding) lesions from the same patient. Non-responding lesions exhibited acanthotic epidermis, had low number of total, proliferative, and differentiated melanocyte (MC) populations, and increased number of senescent keratinocytes (KCs) and of cytotoxic CD8+ T cells as compared with responding lesions. The abnormal response in the non-responding lesions was driven by a dysregulated cAMP pathway and of upstream activator PDE4B, and of WNT/β-catenin repigmentation pathway. Vitiligo-responding lesions expressed high levels of WNT10B ligand, a molecule that may prevent epidermal senescence induced by NBUVB, and that in cultured melanoblasts prevented the pro-melanogenic effect of α-MSH. Understanding the pathways that govern lack of NBUVB-induced vitiligo repigmentation has a great promise in guiding the development of new therapeutic strategies for vitiligo.
Insights
Vitiligo patients resistant to narrow-band UVB (NBUVB) therapy show distinct cellular changes and molecular pathway dysregulation. Understanding these mechanisms is key to developing new vitiligo treatments.
Area of Science:
- Dermatology
- Immunology
- Molecular Biology
Background:
- Vitiligo is a condition causing skin depigmentation.
- Narrow-band UVB (NBUVB) is a common treatment, but some patients show resistance.
- Cellular and molecular differences in non-responding vitiligo lesions are not fully understood.
Purpose of the Study:
- To investigate the cellular and molecular pathways underlying localized NBUVB treatment resistance in human vitiligo.
- To compare non-responding and responding vitiligo lesions within the same patient.
Main Methods:
- Analysis of paired skin biopsies from vitiligo patients (non-responding vs. responding lesions).
- Techniques included immunostaining, RNA-sequencing (RNA-Seq), and in situ hybridization.
- Evaluation of epidermal structure, melanocyte populations, keratinocyte senescence, and immune cell infiltration.
Main Results:
- Non-responding lesions had thicker epidermis, fewer melanocytes, increased senescent keratinocytes, and more cytotoxic CD8+ T cells.
- Dysregulated cAMP and WNT/β-catenin pathways were identified in non-responding lesions.
- Responding lesions showed high WNT10B levels, potentially preventing keratinocyte senescence.
Conclusions:
- Localized NBUVB resistance in vitiligo is associated with specific cellular and molecular alterations.
- Dysregulation of cAMP, PDE4B, and WNT pathways contributes to treatment failure.
- Identifying these pathways offers potential for novel therapeutic strategies for vitiligo.
More Related Videos
08:26Isolation and Culture of Adult Epithelial Stem Cells from Human Skin
Published on: March 31, 2011
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Clinical Applications of Epidermal Stem Cells
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Renewal of Skin Epidermal Stem Cells
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...